DTIL - PRECISION BIOSCIENCES INC
5.18
0.080 1.544%
Share volume: 88,010
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$5.10
0.08
0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2023 | 08-04-2023 | 11-07-2023 | 03-27-2024 | 05-13-2024 | 08-01-2024 | 11-04-2024 | 03-26-2025 | |
| Total revenue | 8.780 M | 19.789 M | 13.120 M | 7.038 M | 17.584 M | 49.898 M | 576.000 K | 638.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 8.780 M | 19.789 M | 13.120 M | 7.038 M | 17.584 M | 49.898 M | 576.000 K | 638.000 K | |
| 125.39% | -33.70% | -46.36% | 149.84% | 183.77% | -98.85% | 10.76% | |||
| Operating expenses | 33.244 M | 31.776 M | 25.483 M | 1.960 M | 21.771 M | 25.752 M | 21.851 M | 25.484 M | |
| Selling general and admin | 11.086 M | 9.830 M | 9.633 M | 8.539 M | 8.428 M | 8.527 M | 8.767 M | 9.577 M | |
| Research and development | 22.158 M | 21.946 M | 15.850 M | -6.579 M | 13.343 M | 17.225 M | 13.084 M | 15.907 M | |
| Total expenses | 34.585 M | 31.776 M | 26.833 M | 2.831 M | 21.771 M | 25.941 M | 21.851 M | 25.295 M | |
| -8.12% | -15.56% | -89.45% | 669.02% | 19.15% | -15.77% | 15.76% | |||
| Operating income | -25.805 M | -11.987 M | -13.713 M | 4.207 M | -4.187 M | 24.146 M | -21.275 M | -24.846 M | |
| Ebit | -25.805 M | -11.987 M | -13.713 M | 4.207 M | 5.786 M | 32.605 M | -17.057 M | -18.064 M | |
| Pretax income | -25.060 M | -11.891 M | -12.110 M | 6.534 M | 8.588 M | 32.938 M | -16.425 M | -17.934 M | |
| -52.55% | 1.84% | -153.96% | 31.44% | 283.54% | -149.87% | 9.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -25.060 M | -11.891 M | -8.079 M | -16.289 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| 52.55% | 32.06% | -101.62% | 100.00% | ||||||
| Net income | -25.060 M | -11.891 M | -8.079 M | -16.289 M | 8.588 M | 32.749 M | -16.425 M | -17.745 M | |
| 52.55% | 32.06% | -101.62% | 152.72% | 281.33% | -150.15% | -8.04% |
